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ABSTRACT
Microcurrent therapy is unique amongst the electrophysical modalities in applying electric fields and currents 
of similar form and magnitude to those produced naturally by the body. The therapy involves application of 
electric currents of the order of millionths of an amp, and there is evidence that it can promote healing in a 
variety of damaged tissues. Clinical trial evidence indicates that the therapy may be effective with non-uniting 
fractures, spinal fusions and a skin ulcers of varying aetiology, particularly where other forms of treatment 
have not been successful. In vitro, animal and human studies also suggest that there is unexplored potential 
for the application of microcurrent to a variety of musculoskeletal disorders. However, higher quality and more 
comprehensive clinical trial data may be required before musculoskeletal clinicians consider adding this 
modality to their electrotherapy repertoire.
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INTRODUCTION
Contemporary accounts of tissue healing are typically expressed entirely in terms of biochemistry1-4. The 
actions of substances such as cytokines and  growth factors are said to initiate and mediate the various stages 
of inflammation and repair that normally follow tissue damage5. Yet evidence has accumulated over many 
decades that a full description of the physiology of healing must also include the role of bioelectricity, 
accumulations and flows of charge that are generated endogenously - within the body. The importance of 
bioelectricity in functions such as nervous system signalling and muscle contraction has been long recognised, 
but it is involved in many other physiological processes. These include the development, adaptation, repair 
and regeneration of tissues throughout the body6-9. 
Recognition of bioelectricity’s role in tissue healing provides a rationale for the therapeutic application of 
electrical stimulation, particularly in cases where natural repair processes have broken down. Microcurrent 
therapy (MCT) is an example of this. Uniquely amongst the various electrotherapeutic modalities, MCT 
involves application of voltages and currents of similar magnitude to those generated endogenously during 
normal tissue healing. Although relatively unknown and currently little used by physiotherapists, MCT has 
been shown to be of benefit in  several types of tissue healing and it may be effective in others. It has 
advantages of stimulating healing generally, and not just one element of the process; it has very few side 
effects; and it may offer an effective treatment for musculoskeletal disorders such as tendinopathies where 
endogenous healing  appears to be dysfunctional.
This paper outlines current thinking on the role of bioelectricity in healing, presents empirical evidence 
regarding MCT for the promotion of tissue healing, and suggests implications for both clinical and research 
communities. The majority of published research in this area is concerned with bone and skin lesions, but 
patterns and mechanisms of healing in these tissues share features with those seen in damaged tendons, 
ligaments and other musculoskeletal structures10-12. Therefore the evidence presented here is of relevance to 
researchers and clinicians concerned with a variety of musculoskeletal disorders.
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Bioelectricity and healing
The human body, in common with other living organisms, expends a significant proportion of its energy 
generating electricity13. In fact the body is a conglomeration of electric batteries. Every cell maintains a voltage 
across its external membrane, and across the membranes of its organelles14, 15. This is achieved by the active 
transport of ions, particularly sodium (Na+) and Potassium (K+),  against their concentration gradients, 
establishing charge separations that constitute a potential difference or voltage across the membrane16. 
Aggregates of cells also set up voltages across various tissue layers, cutaneous and corneal epithelium, vascular 
and intestinal walls, and the cortex and periosteum of long bones14, 15, 17-21. These voltages are of the order of 
millvolts (mV) in magnitude, and where there is a conducting pathway they cause the movement of ions within 
tissue, constituting a bioelectric current, typically in the microamp (μA) range14.
At the cellular level, bioelectricity is involved in the transport through the membrane of ions that can mediate 
cell  behaviour. Even in non-excitable cells there are voltage-gated channels controlling the passage of ions 
that mediate cell behaviour22. At the tissue level, endogenous fields are intrinsic to a number of metabolic 
processes, including development, adaptation and repair. They can influence cell morphology and the growth 
of body parts during foetal development13, 23, 24; they are generated when connective tissues such as bone and 
tendon are stressed and can influence adaptive modifications in the extracellular matrix25-28; and when tissue 
is damaged they set up currents that appear to drive elements of the healing response17, 29-32. The currents 
diminish as healing progresses, with normal values being re-established once healing is complete 17, 23, 32, 33.
That bioelectricity is intrinsic to such processes – rather than mere by-products – has been established by a 
wealth of experimental evidence. Perhaps the most convincing is that setting up a voltage in opposition to the 
endogenous one, or blocking the passage of biocurrents in wounds, can slow or abolish the healing response in 
a variety of tissue types 15, 33-35. In vitro studies have also demonstrated that application of electric fields and 
currents similar to those generated within the body can cause significant changes in the structure and 
behaviour of cells. Application of microcurrent to tissue has been found to boost the number of organelles 
responsible for cellular activities, and to increase concentrations of ATP, the cellular currency of energy36, 37. 
These changes can facilitate cell proliferation and protein synthesis, which have been found to increase when 
microcurrents are applied to the constituent cells of skin38, 39, tendons40, 41, cartilage42 and bone43. Such effects 
are highly parameter-dependent, however. Larger currents or alternating microcurrents at certain frequencies 
have been found to reduce cell proliferation or induce cell death in some cases44, 45. 
Ion channels in cell membranes may migrate under the influence of an applied field, resulting in cytoskeletal 
modifications, including creation of membrane projections that cause cell movement24, 37. Directed movement 
of cells within an electric  field – known as galvanotaxis – has been observed with many cell types. These 
include leukocytes and macrophages, which are key mediators in different stages of healing46, as well as a 
variety of cells responsible for tissue formation, such as keratinocytes, vascular endothelial cells, osteoblasts, 
osteoclasts, chondrocytes and fibroblasts 24, 37, 47, 48. Different cell types have been found to move in opposite 
directions, and reversing the field reverses the direction of migration37, 49. 
At the tissue level, unidirectional fields and direct currents (DC) can promote vascular permeability50
angiogenesis51 and neural sprouting31, 52 as well as formation of new skin, bone, cartilage and soft tissue 
formation 39, 53-57. Such findings are significant because they suggest that applying fields and currents with 
similar parameters to bioelectricity may be used to stimulate tissue healing. Cell migration, proliferation and 
synthesis of new tissue are all essential components of the healing process 1, 46. If applied electricity can mimic 
endogenous electrical signals that guide cellular behaviour, then a therapeutic option may be available where 
natural healing has failed.
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Therapeutic Microcurrent 
There are various forms of electrotherapy that may deliver average currents in the microamp range, such as 
high voltage pulsed current (HVPC) and high frequency alternating currents induced by electric or 
electromagnetic fields (e.g. Pulsed Short-wave Therapy). However, the waveforms produced by these 
modalities are quite unlike those of any observed endogenous currents and voltages, which tend to be 
unidirectional, and of constant or slowly varying amplitude14. Since MCT is predicated on the basis that it 
mimics endogenous bioelectric signals,  the main focus here is on those studies that use electrical stimulation 
with similar parameters. A good deal of evidence regarding the effects of microcurrent on tissue healing has 
accumulated over recent decades. Where clinical trials have been reported, they are presented, though 
reference to in vitro and animal studies is also made where clinical trial data is scarce. 
BONE
Electrical stimulation was used for promotion of bone healing in the early 19th century. English physician John 
Birch applied direct current to the ends of a 13 month-old non-uniting tibial fracture via percutaneous 
electrodes58. After 6 weeks of treatment the fracture had consolidated. Other historical examples of electricity
being used in this way era are recorded, but the therapy later fell into disuse. It was revived in the mid 20th
century, when a scientific rationale for its application was developed on the basis of in vitro and animal 
experiments. In the 1950s several workers found that application of microcurrent to bone could initiate 
osteogenesis in both normal and damaged bone 59, 60. Later studies investigated the effects of parameters such 
as current size, polarity and electrode material and configuration on the process 61-63. New bone could be laid 
down by direct currents of about 20 μA, with maximal formation occurring at the cathode (the negative 
electrode). Currents above 30 μA could cause bone resorption or osteonecrosis 55, 62, 64. Such data provide a 
convincing rationale for the use of microcurrent to stimulated bone healing, and subsequent in vivo animal 
studies suggested that it might be beneficial for several clinical applications, including fresh fractures, delayed 
and non-uniting fractures, osteotomies and spinal fusions, although parameter choices varied considerably 
and not all applications were successful 65-70. For reviews of such studies, see 71, 72.
Clinical studies
The earliest modern application of MCT for human bone healing was to non-uniting fractures. In 1971, 
Friedenberg and colleagues published a case study in which a malleolar fracture, which had failed to unite 
after more than a year, was healed by treatment with direct current of 10 μA via a cathode inserted into the 
fracture site73. Several larger studies followed, in which MCT was applied to delayed or non-uniting fractures. 
Delayed unions are those that take longer than would be expected for the particular fracture site and patient 
characteristics; non-union is said to occur when healing stops and union is not achieved after 6 – 8 months74. 
In 1977 Brighton and colleagues reported a study involving treatment of 57 lower and upper limb non-unions 
with 10 - 20 μA, delivered to the site by 2 - 4 cathodes for 12 weeks, followed by 12 weeks further 
immobilisation75. Of those treated, 76% went on to develop full union, with most failures accounted for by 
insufficient current delivery or breakage of electrodes. In a follow-up multi-centre study 84% of 178 non-
unions treated using a similar protocol achieved union. Complications were reported as minor76. Another 
multicentre trial in a different country used the same current but delivered through a single cathode to 84 
patients with either delayed or non-union77, mostly of the tibia or femur. Time to achieve union varied 
between 12 and 36 weeks. A ten-year follow-up assessment of 37 of the patients enrolled in this trial found 
normal bone remodelling, continued union and no side effects of the electrodes that were left in situ (the 
remaining participants were unavailable for review)78. 
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Microcurrent pulsed at 20 Hz has also been evaluated and found beneficial with a mixed caseload of non-
uniting fractures, congenital pseudarthroses, osteotomies and leg-lengthening procedures.  DC of pulse 
amplitude 20 – 25 μA and duration 30 ms was applied via a cathode wrapped around or threaded through the 
fracture site and with the anode implanted in the medulla (as opposed to the subcutaneous positioning used 
in other trials). Treatment times varied according to case until union was observed radiographically, and varied 
between 2 and 12 months. The overall success rate was 87% although adjunctive treatments and individual 
characteristics varied considerably. Authors of one of the earlier studies75 reported that they found that 
constant DC always produced superior outcomes to pulsed current, although they presented no relevant 
parameter or outcome data.
Some of these studies are rather dated and do not meet contemporary reporting standards for clinical trials. 
The absence of a formal control group is justified by the fact that usually no bone healing had been observed 
for months, and spontaneous recovery in such cases is rare, so participants were considered to be acting as 
their own controls76. However placebo and time effects cannot be ruled out when evaluating their evidence. 
The lack of more recent studies may reflect the greater popularity of less invasive electrotherapeutic 
modalities79, although MCT may give superior results in selected cases. A comparison with capacitative and 
inductive coupling as adjuncts for bone graft treatment of tibial non-unions reported in 1995 found that 
microcurrent was more effective with high risk cases such as those with atrophic non-unions or previous graft 
failure80. Where there were no identified risk factors, none of the electrotherapies was superior to graft alone.
Although non-invasive forms of electrotherapy have superseded MCT for some applications, it has continued 
to be employed in selected cases of lumbar spinal fusions, where there is evidence of its superiority over other 
modalities. Lumbar spinal fusions are used in cases of disabling joint instability or disc degeneration, and 
normally involve a bone graft and instrumentation. Failure rates can be as high as 40%81, but may be reduced 
substantially by the application of MCT. After its first clinical use was reported in 197482, direct current 
application, typically of 20 μA applied by a single or multiple cathodes to the fusion site for 5-6 months, was 
subject to evaluation in several trials83-85. In these studies patients receiving MCT in addition to standard 
treatment had successful fusion rates of 81 – 96%, compared to 54 – 81% for those on standard treatment 
alone, as assessed by radiographic and clinical criteria. Results for methodologically sound controlled trials 
consistently indicate statistically significant outcomes in favour of  DC MCT compared with control groups86. It 
is particularly effective when used in high risk cases such as those with previous failed fusions, multiple level 
surgery, smokers and those with co-morbidities such as diabetes and obesity87-89, and has a stronger evidence 
base in its favour than either CC or IC, particularly for posterior fusions90. An economic evaluation of the 
therapy as an adjunct in spinal fusion surgery91 also found that it provided significant cost savings and shorter 
in-patient stays.  
Other small studies have suggested that DC MCT may be useful in other bone lesions, including high risk ankle 
and hind-foot fusions92, 93 and selected congenital pseudarthoses94-97. Their findings have yet to be confirmed 
in larger trials. Two controlled trials have suggested that MCT may also accelerate healing in fresh fractures98, 
99, though this application is still largely unexplored. 
Systematic reviews of trials have concluded that the best evidence for promotion of bone healing by 
application of small electric currents is in cases of non-uniting lower limb fractures and spinal fusions71, 86, 88, 90, 
100-105. Meta-analyses have been weakened by pooling data from trials using heterogeneous groups and 
treatment parameters, and even different forms of electrotherapy 86, 101. Nevertheless, consideration of the 
evidence regarding MCT in particular suggests that its application, usually for several months, may enhance 
tissue healing in a variety of bone lesions. 
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SKIN
Since it is easily accessible for study, skin is the tissue in which the bioelectrics of healing have perhaps been 
subject to the greatest scrutiny. Several reviews providing accounts of in vitro and animal studies are 
available53, 72, 106, and only the human and clinical studies are dealt with here. Several authors have identified 
the seventeenth century use of charged gold leaf for resolution of smallpox lesions as the first example of 
electrotherapy for human skin healing53, 107, 108. In fact there is no mention of electric charge in the cited 
source109. Charged gold leaf, which would deliver small and diminishing currents to adjacent tissue, was used 
successfully in the 1960s to assist healing in surgical vascular wounds and cutaneous ulcers110, 111. However, 
charging appears to have been considered an aid to adherence of the leaf rather than an agent of healing in 
itself. Nevertheless, more recent studies have consistently concluded that electrical stimulation, including 
MCT, can indeed promote healing in various types of human skin wounds, particularly ulcers. The first of these 
was reported in 1968 by Assimacopoulos who, following successful use of microcurrent to accelerate healing 
of surgical scars on rabbit ears112, tried the treatment with recalcitrant leg ulcers in three patients113. Direct 
current between 50 and 100 μA was delivered continuously for several weeks via a stainless steel mesh 
cathode soaked in saline and placed on a moist dressing on the wound, and an anode affixed to the thigh or 
abdominal wall. All the wounds healed within 6 weeks ands no side effects of treatment were reported. 
In a larger study, Wolcott and colleagues used MCT with 83 ulcers of varying aetiology in 67 patients114. A 
measure of control was introduced by assessing but not treating additional ulcers in eight of the sample 
patients. “About three quarters” of the patients had failed to respond to other conservative treatment. Direct 
current between 400 and 800 μA was applied via a copper mesh cathode over the wound and anode on skin 
15cm proximal. The current level was determined individually, adjusted so as to avoid bleeding or excess 
exudate production, and was delivered for 2 hours, thrice daily for several weeks, is some cases months, until 
healing occurred (a full breakdown of durations was not given). The protocol involved a polarity-swapping 
element, based on early experience that healing would often plateau after a few days and could be restarted 
by reversing the polarity of the electrodes. Over a mean treatment time of 7.7 weeks, there was a mean 
volume reduction in treated wounds of 82%, with a mean healing rate of 13.4% per week. 34 lesions (40%) 
healed completely. These figures mask a wide range of individual and group responses, with paraplegic 
patients (presumably mostly spinal cord injured) consistently responding less well to treatment. Of the eight 
patients (mostly paraplegic) with microcurrent-treated and control ulcers, mean volume reductions were 93 
(range 75 – 100) % in the MCT ulcers and 33 (range 0 – 75) % in the control ulcers. The study evidence is 
weakened by the lack of information on duration of ulcers, the inclusion of patients for whom standard 
treatments had not been tried, early termination of electrotherapy protocol in more than half of the sample, 
and the small size of the control group. Even so, it began to build the case that MCT could assist healing in a 
variety of skin ulcer types.
MCT using similar protocols – and various alternatives - were later used in several larger controlled trials by 
other groups115-121. These involved a variety of skin ulcer types including those due to venous and arterial 
insufficiency, secondary to diabetes, and pressure ulcers following spinal cord injury. MCT typically involved 
currents of the order of several hundred microamps, often continuous DC but sometimes pulsed or low 
frequency biphasic. Where currents were unidirectional, the anode was normally placed on the wound, within 
a moist dressing. Treatment times were usually an hour or more each day for several weeks or even months. 
Healing was measured in terms of percentage reductions in wound surface area or volume over a defined 
time, and in the majority of cases ulcers receiving MCT as an adjunct to conventional treatment healed more 
quickly and completely than those receiving conventional treatment alone.
More recent studies have suggested that MCT may also be effective with other types of skin wounds. In a trial 
involving 30 patients, microcurrent of was found more effective than conventional treatment in promoting 
skin graft healing following thermal injury122. A DC current between 50 and 100 μA was applied continuously 
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for several days via an anodal dressing on the wound. Stimulated wounds closed in an average 4.6 days 
compared to 7.2 days for controls. A series of case studies involving application of monophasic microcurrent to 
pressure sores, an infected venous ulcer and a recalcitrant pilonidal sinus also found evidence of benefit in 
terms of 123 accelerated healing and reduction of bacterial load. The novelty of these cases was that the 
current (of unspecified magnitude) was provided by a proprietary dressing with an integrated circuit and 
battery and electrodes.
Reviews of electrical stimulation for skin wound healing have consistently concluded that the weight of 
evidence is in its favour when it is used as adjunctive treatment with other conservative management 
strategies 53, 86, 108, 124-128. In the USA, government and private medical insurers pay for its use with recalcitrant 
ulcers due to pressure, arterial or venous insufficiency and diabetes 127. However most reviews have not 
considered the different modalities separately, because the numbers would not justify subgroup analysis. 
Where MCT studies are considered alone, the range of protocols employed means that optimum parameters 
cannot yet be identified. Both continuous and pulsed, monophasic and biphasic, anodal and cathodal 
stimulation seem capable of promoting healing. The parameters that are supported by a majority of studies 
are current size (in the hundreds of microamps), treatment time (typically several weeks, for hours rather than 
minutes each day) and application directly to the wound bed. Monophasic or “unbalanced” currents (those 
with a net delivery of charge) are more common in the studies indicating MCT effectiveness.
TENDONS AND OTHER TISSUES
Data from in vitro and animal studies, and a small number of human trials, suggest that there may be 
unexplored potential for microcurrent treatment of soft connective tissue lesions, particularly in tendons and 
ligaments. In these structures, the extracellular matrix (ECM) is laid down by various phenotypes of the 
fibroblast, a cell that has been shown to migrate, proliferate and increase synthesis of ECM proteins under the 
influence of applied electric fields and currents40, 41, 129-132. 
Tissue and animal studies
By using explants, whole tissue samples taken from animals and maintained in laboratory cultures, 
investigators have been able to conduct well-controlled studies of the effects of applied current on tendons 
and ligaments.  Nessler and Mass reported using these methods in 1987, when they applied continuous 7 μA 
current for up to 6 weeks to surgically transected and sutured rabbit flexor tendon explants133. Bioassay and 
histological analysis showed greater and more rapid fibroblast proliferation, protein synthesis and collagen 
deposition consistent with normal tendon healing in stimulated explants compared to their controls. These 
changes were observed distant from the cathode, which had been placed into the lesion, and the authors 
speculated that the current density was too great close to the cathode. Soon after, Cleary and colleagues 
investigated the influence of various microcurrent parameters by applying pulsed monophasic microcurrent to 
chicken flexor tendon explants for three days, varying current amplitude, direction and pulsing frequency130. 
They found that levels of fibroblast proliferation, protein synthesis and collagen fibroplasia at the cut surfaces 
of stimulated explants were significantly greater than those of unstimulated controls. Effect sizes were 
greatest at current densities of near 1 μA/cm2, and at pulse frequency 1 Hz, and dropped off at higher values. 
Applying the current longitudinally maximised the effects, whilst no significant differences between treated 
and control explants were found with transverse application. This observation was explained by other studies 
showing that fibroblasts lay down collagen fibres parallel to the direction of the applied field134, 135.
In a study using explants of rabbit flexor tendons and their sheaths, longitudinal stimulation with various DC 
microcurrent levels was applied for up to 2 weeks41. Investigation of the cut surfaces revealed evidence of cell 
proliferation and collagen deposition in both treated and control samples, with adhesions forming in the 
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epitenon-sheath as a result. Application of microcurrent caused different effects according to current size. 
Above 1 μA there was evidence of tissue degeneration and cell death, but at 0.5 μA proliferation continued in 
the tendon substance but was significantly reduced in the sheath. This observation rather astonishingly 
suggests that microcurrent can selectively inhibit proliferation that would lead to counterproductive adhesion 
formation during sheathed-tendon healing. 
In the first reported in vivo animal study, low level current was applied to surgically wounded flexor tendons of 
6 ponies via a cathode implanted in the wound and an anode 3cm distal136. No gross or histological differences 
were seen between treated and contralateral control tendons at 4, 5 and 6 weeks post-injury. The author 
speculated that the (unmonitored) current, provided by a bimetallic strip, may have been too low to affect 
healing. Later studies were more encouraging, though a wide range of parameters was adopted, making 
generalisation from their results problematic. Stanish and colleagues transected the medial portion of the 
patellar tendons of nine dogs and divided them into three groups, receiving plaster immobilisation, brief 
compression bandaging or constant 20 μA current applied via a cathode wrapped around the tendon137. After 
six weeks the dogs were killed and the tendons removed with their contralateral counterparts for comparison. 
Breaking strengths as a percentage of the normal tendon values were 47% and 50% for the first two groups, 
and 92% for the MCT group. Though the sample sizes were small, the difference is striking.
In a larger study138, the patellar tendons of 45 rabbits were transected bilaterally and cathodes sutured into 
the lesions, anodes mounted on the tissue surface. One limb was left untreated, the other given 10 μA DC 
continuously, with tendons removed at for three, five or seven weeks for evaluation. Mechanical strength was 
found to increase more rapidly in the early weeks in stimulated tendons, whilst mature collagen formation was 
greater in the later weeks, compared to controls. This suggested that MCT could accelerate healing in both 
proliferative and remodelling phases of healing.
Subsequent studies with rat Achilles tendons, knee ligaments and joint capsules have consistently suggested 
that MCT with a range of parameters can accelerate repair and result in stronger tissue and reduced 
contracture formation after injury, compared to unstimulated controls56, 139-143. Microcurrent has also been
observed to promote rabbit cartilage growth57 and repair144, as well as  rat peripheral nerve regeneration52.  
DC or unbalanced biphasic current was used in all the tendon studies, but AC was also successfully employed 
with other tissues. Treatment times varied between one and 24 hours a day for between one and four weeks. 
Where currents were modulated, their amplitudes were of the order of 100 μA (with considerably lower 
average values), and electrodes were implanted, usually delivering current parallel to fibre orientation. The 
strength of the studies is in their use of contralateral controls, allowing a cause-effect relationship to be 
established. However their findings cannot be aggregated because of heterogeneity in their treatment 
parameters. They all used surgical means to create lesions and animal models that are imperfect analogues of 
human tissue disorders. The lack of histological data also means that conclusions cannot be drawn about 
repair processes. Despite these limitations, they provide evidence that microcurrent can promote resolution of 
tissue damage, and have justified progression to clinical trials of MCT.
Human studies
Following their work with surgically wounded canine tendons, Stanish and colleagues reported on a series of 
more than 100 patients in which MCT was used after surgical repair of torn Achilles and patellar tendons and 
anterior cruciate ligaments. A direct current of 20 μA was applied (for an unreported time, presumably several 
weeks)  via a cathode wrapped around the lesion and a subcutaneous anode and power-pack. The authors 
reported accelerated return to full weight-bearing and function, and histological analysis of 45 reconstructed 
ligaments  9 months after surgery showed the tissue to be revascularised with mature and well organised 
collagen. This was not a formally controlled trial, however, and little numerical data is provided for scrutiny.
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MCT has been subject to trial with several examples of chronic tendinopathy. One involved 48 people with 
Achilles tendinopathy of at least 3 months system duration, randomly assigned to receive either microcurrent 
or conventional conservative treatment145. A monophasic square wave of amplitude 40 μA and frequency 10Hz 
was applied via surface electrodes placed transversely across the lesion. Treatment was for 30 minutes daily 
over 14 days, followed by a regime of eccentric exercises. Numerical measures of patient-rated pain and 
stiffness and clinician-rated clinical status were recorded at baseline and at 3, 6 and 12 months after 
treatment. Statistically significant differences in favour of the MCT group were found in these measures. 
Sonography, which can be used to image changes associated with tendinopathy146, 147, was also employed. The 
authors reported that sonographic findings were “in agreement” with these outcomes, though specific data 
are not given. Improvements were most marked in the first three months after treatment. The study is 
weakened by non-standardisation of the conventional treatment and a complex and unvalidated scoring 
system used with the outcome measures. However, the data are encouraging.
A more recent pilot controlled trial has used MCT for chronic tennis elbow148. Sixteen people with symptoms 
lasting at least 3 months were randomly assigned to receive either a 6-week standardised exercise programme 
or exercise plus MCT.  Biphasic square wave current with a variety of parameters including amplitudes 40 μA 
or 300 μA and frequencies of 0.3, 3 and 30 Hz. Treatment was administered via probes contacting the skin at 
various points on the elbow and forearm for several minutes, ten times over three weeks. Outcome measures 
were pressure pain threshold at the tendon, grip strength and pain on gripping, recorded at baseline and 1, 2, 
3 and 6 weeks later. All participants improved but no significant differences between groups were seen in any 
of the outcome measures. The conclusions may have been affected by the small sample size of the study, but 
in any case it was hampered at the outset by the use of MCT with very short duration and methods of 
application that were given no scientific justification by the authors.
Trials using microcurrent have been reported for a range of other soft tissue lesions, including plantar 
fasciitis149, delayed-onset muscle soreness (DOMS)150-152, radiation-induced fibrosis153 and osteoarthritis154. The 
outcomes of these trials suggest – though not unequivocally - the MCT may have an analgesic effect that is not 
due to sensory stimulation, since the treatment is normally sub-sensory. Pain relief may account for the 
improvement in other outcome measures such as range of movement and function. In one study there was 
also evidence of mediation of the healing process. Serum creatine kinase (CK) levels, which elevate following 
muscle damage, were found to be lower in DOMS-induced muscles after MCT than in an untreated control 
group. The microcurrent was delivered by a skin-mounted charged dielectric pad, providing an average 20μA 
over 48 hours, and the CK level differences were significantly lower in the treated group 4-7 days after injury 
151. 
Drawing firm conclusions from these human studies is hampered by various factors. In particular, the use of 
proprietary devices delivering microcurrent whose parameters are based on little if any scientific rationale. 
The outcome measured they adopt often give only indirect information about tissue status, and some studies 
are poorly constructed or reported. Nevertheless they suggest that MCT may have potential in promoting the 
resolution of various musculoskeletal soft tissue disorders, and indicate the need for well-conducted clinical 
trials. The normally sub-sensory nature of  microcurrent means that double-blind placebo-controlled trials, 
which could provide convincing evidence, are practicable. However, at least for the present, the most robust 
evidence in favour of MCT for soft tissue lesions is provided by cellular and animal studies. 
CONCLUSIONS
The evidence in support of MCT has been convincing enough to justify its inclusion in the clinician’s repertoire 
for treatment of several examples of recalcitrant bone and skin lesions. Indeed federal and private health 
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insurance providers in the USA have accepted its use (along with other forms of electrical stimulation) for 
spinal fusions and hard to heal skin ulcers for some years53, 83. In contrast, the lack of substantial and robust 
human trial evidence for the use of MCT with musculoskeletal soft tissue lesions is frustrating. Clinicians are 
justifiably cautious when presented with yet another form of electrotherapy, especially when the case for 
more familiar and well-used modalities such as therapeutic ultrasound has been questioned in several 
reviews155-157. 
Yet MCT has several significant features in its favour: there is already substantial evidence that it can promote 
healing in a variety of tissue types and disorders, especially where other approaches have failed; it may help 
redress an underlying physiological dysfunction as well as reducing its symptoms; its mechanism of action 
appears to be as a trigger or facilitator of the healing process, unlike some new approaches such as exogenous 
growth factors, which have specific targets in the healing cascade. Reported side-effects of MCT are few and 
minor, and it can be provided by a small, portable generator, over an extended period where necessary, 
requiring minimal therapist supervision once initiated. The therapy has been shown to be most beneficial 
when it is used as part of a broader management strategy. Given these characteristics, the potential for MCT in 
a range of recalcitrant  musculoskeletal disorders is worthy of closer attention by both research and clinical 
communities. 
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